The present study comparing TAVI and SAVR highlights the importance of tailoring treatment strategies to individual patient profiles, particularly in the context of SAA. Identifying the most suitable candidates for each approach requires a nuanced understanding of anatomical, procedural, and patient-specific factors, as well as the long-term ...

1 天前 · A systematic review identified six eligible RCTs, comprising 2,668 patients who underwent TAVI and 2,573 who underwent SAVR, with a mean follow-up duration of 3.02 years. Their findings demonstrated that TAVI was associated with a significantly lower risk of all-cause mortality ([RR] 0.68, 95% [CI] 0.52–0.88) and a reduced incidence of the ...

Aortic regurgitation, paravalvular regurgitation, major vascular complications, and pacemaker placement favoured surgical aortic valve replacement (SAVR) over TAVI. TAVI remained superior to SAVR in major bleeding and renal failure events. Long-term data on newer generation valves and up-to-date implantation techniques may provide better ...

2022年5月2日 · TAVI with contemporary devices appears to be safe and effective for elderly patients with bicuspid AS; however, SAVR should remain the primary treatment option for bicuspid AS in young patients and independent of age when the bicuspid aortic valve morphology is unfavorable or significant aortopathy coexists.

2023年11月6日 · While there are several ways to replace your aortic valve, TAVR and SAVR differ significantly in their approach and recovery. TAVR is a procedure, while SAVR is a surgery.

经导管主动脉瓣置换术（TAVR）又称经导管主动脉瓣植入术（TAVI），是指将组装完备的人工主动脉瓣经导管置入到病变的主动脉瓣处，置换原有主动脉瓣，在功能上完成主动脉瓣的替代。 近年来，TAVR已经成为老年主动脉瓣狭窄（AS）患者的一线治疗方案，为原本失去外科手术机会的老年患者提供了一种新的选择。 对于主动脉瓣狭窄患者，什么情况下选择TAVR或SAVR？ 瓣膜选择生物瓣还是机械瓣？ 关于SAVR/TAVI的选择. 2020 ACC/AHA瓣膜管理指南： 既往指南中， …

2022年9月7日 · 近期，EHJ杂志发表了一项综述，系统性回顾了TAVI和SAVR之间的决策过程和治疗选择的关键证据，重点聚焦被排除在随机临床试验之外的人群，并提出了重度主动脉瓣狭窄患者的终身管理策略。 TAVI和SAVR的选择. 解剖学危险分层. 解剖结构是选择治疗方式的主要考虑因素之一。 对于主动脉瓣解剖有利于TAVI且经股静脉入路可行的情况下，TAVI与SAVR获益相当；相反，若解剖学结构不利于TAVI或经股静脉入路不佳，应选择SAVR。 尽管如此，对于一些中等 …

2024年10月18日 · TAVR was associated with a significantly lower risk of cardiovascular mortality, disabling stroke, rehospitalization, new‐onset atrial fibrillation, and a higher risk of permanent pacemaker implantation compared with SAVR during the 30‐day follow‐up.

2023年2月13日 · TAVR：经导管主动脉瓣置换术（Transcatheter aortic valve replacement）； SAVR：外科主动脉瓣置换术（Surgical aortic valve replacement） 在 TAVR 不断扩大使用的时代，何时参考 SAVR ？ 最新的综述为TAVR试验中未涉及的人群提供了指导。

Transcatheter aortic valve replacement (TAVR) was approved in the United States in late 2011, providing a critically needed alternative therapy for patients with severe aortic stenosis previously refused surgical aortic valve replacement (SAVR).